Drug Shortage Report for TPN ELECTROLYTES
Report ID | 153231 |
Drug Identification Number | 00590215 |
Brand name | TPN ELECTROLYTES |
Common or Proper name | TPN ELECTROLYTES |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE SODIUM ACETATE MAGNESIUM CHLORIDE POTASSIUM CHLORIDE CALCIUM CHLORIDE |
Strength(s) | 16.05MG 121MG 25.4MG 74.55MG 16.55MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 20mL vial |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-04-01 |
Estimated end date | |
Actual end date | 2022-09-07 |
Shortage status | Resolved |
Updated date | 2022-09-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-01-20 | English | Compare |
v2 | 2022-01-20 | French | Compare |
v3 | 2022-03-11 | English | Compare |
v4 | 2022-03-11 | French | Compare |
v5 | 2022-04-02 | English | Compare |
v6 | 2022-04-27 | English | Compare |
v7 | 2022-04-27 | French | Compare |
v8 | 2022-08-02 | English | Compare |
v9 | 2022-08-02 | French | Compare |
v10 | 2022-09-07 | English | Compare |
v11 | 2022-09-07 | French | Compare |
v12 | 2022-09-08 | English | Compare |
Showing 1 to 12 of 12